Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
BioSpace
BioSpace
Futurism Tech Brief By HackerNoon
HackerNoon
Science Tech Brief By HackerNoon
HackerNoon
My Weird Prompts
Daniel Rosehill
TED-Ed
TED-Ed
Cultivating Place
Jennifer Jewell / Cultivating Place
Life’s Tough, Explorers Are TOUGHER!
Richard Wiese
Dark Mysteries — Unsolved Mysteries. Forgotten Secrets. Unanswered Questions.
Darkest Mysteries Online
Contacto Siniestro Podcast
Siniestro Producciones
Made of Stars
Wes Carroll
DebateMath Podcast
Chris Luzniak & Rob Baier
Outdoor Journal Radio: The Podcast
Outdoor Journal Radio Podcast Network
Boas, Boas, Boas
MPR Network
The Syncreate Podcast: Empowering Creativity
Melinda Rothouse, PhD
Chicago Weather Daily
Fast Foundations
Clima Diario Ciudad de México
Fast Foundations
Now I Get It, with Dr. Andy
Andrew Winkler
Why Should I Trust You?
Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek
Neville Goddard Daily
Neville Goddard
Daily Short Stories - Ghost and Horror Stories
Sol Good Network
SciFi Cast
solgoodmedia.com
Science Fiction - Daily Short Stories
Sol Good Network
Daily Science Fiction Stories
solgoodmedia.com
Daily Ghost and Horror Stories
solgoodmedia.com
Mind Webs Radio
solgoodmedia.com
Quiet Please
Wyllis Cooper
Stories - Science Fiction
Sol Good Network
The Adventures of Superman
Dashiell Hammett
Pioneer Sci-Fi Radio
solgoodmedia.com
Future Worlds Radio
solgoodmedia.com
Vintage Sci-Fi Radio
solgoodmedia.com
Classic Radio Science Fiction
solgoodmedia.com
Interstellar Sci-Fi Tunes
solgoodmedia.com
Mind Webs
solgoodmedia.com
Science Fiction Radio
solgoodmedia.com
Classic Radio Science Fiction
solgoodmedia.com
Old Time Science Fiction
solgoodmedia.com
Science
BioSpace
A surprising deal from Vertex Pharmaceuticals adds to Big Pharma’s acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for deriske...
The vibe at BIO 2026 in San Diego last week was overwhelmingly positive, with attendees observing noticeable changes at the FDA and an uptick in dealmaking and IPOs. Plus, a top medical journal this week retracted a pivo...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We ex...
This year has been partly defined by a return to M&A. In the first quarter of 2026, biopharma spent nearly $47 billion in acquisitions across 19 deals, and this week, AbbVie notched another one for the second quarter, sc...
In this episode of Denatured, you'll hear from Mark Lowdell, CSO & co-founder at INmuneBio Inc. and Vishwas Seshadri, CEO & director at Abeona Therapeutics. We examine how recessive dystrophic epidermolysis bullosa serve...
Moderna’s mRNA-based flu vaccine made headlines in February when the FDA declined to even review the application. Days later, the agency reversed course, setting a decision date for August and later scheduling an advisor...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll hear from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life sc...
Everything came up roses for Eli Lilly at the American Diabetes Association, as the pharma boasted positive results for its new pill Foundayo and next-gen asset retatrutide—not just for weight loss but also for other ind...
In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hai...
At the American Society of Clinical Oncology (ASCO) annual meeting in Chicago this past weekend, packed plenary sessions from Revolution Medicines and Summit Therapeutics’ Chinese partner Akeso stole the show. For RevMed...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, m...
Eli Lilly has been as acquisitive as ever, striking five new deals in the past week alone. On Tuesday, the company dove into the deep end of vaccine development with three separate buys in the space. Outside of vaccines,...
In this episode of Denatured, as part of our series of the European life science investment ecosystem, you'll be hearing from Regina Hodits, managing director at Angelini Ventures and Sofia Ioannidou, VC partner at Ande...
FDA Commissioner Marty Makary officially resigned last week following reports of his ouster. Then, the acting directors for the agency’s two main review units also left their posts, as did the FDA chief of staff and chie...
In this episode of Denatured, you'll be hearing from Miguel Forte, president of the International Society for Cell and Gene Therapy (ISCT), and John Ellis, co-founder & CEO of Trenchant Bios, speaking live from the ISCT ...
Moments after recording this episode of The Weekly, FDA Commissioner Marty Makary announced his resignation. Reports first circulated last Friday that President Donald Trump had signed off on his ouster. The president in...
In this episode of Denatured, you'll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, co-founder & Chief Medical Officer of Calluna Pharma. We dive into IPF and fibrosis challenges, unpackin...
First quarter earnings continue to roll in, with Pfizer, Eli Lilly, Amgen and more reporting in the past week. While Pfizer beat consensus estimates, it wasn’t enough for analysts, who had greater expectations for the Ne...
First quarter earnings continue to roll in, with Pfizer, Eli Lilly, Amgen and more reporting in the past week. While Pfizer beat consensus estimates, it wasn’t enough for analysts, who had greater expectations for the Ne...
In this episode of Denatured, you'll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, an investor at Mid Atlantic Bio Angels and partner at Alloy Bio Consulting. We discuss why a lif...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.